These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35546936)

  • 1. Depressive Symptoms and PANSS Symptom Dimensions in Patients With Predominant Negative Symptom Schizophrenia: A Network Analysis.
    Demyttenaere K; Anthonis E; Acsai K; Correll CU
    Front Psychiatry; 2022; 13():795866. PubMed ID: 35546936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disentangling the symptoms of schizophrenia: Network analysis in acute phase patients and in patients with predominant negative symptoms.
    Demyttenaere K; Leenaerts N; Acsai K; Sebe B; Laszlovszky I; Barabássy Á; Fonticoli L; Szatmári B; Earley W; Németh G; Correll CU
    Eur Psychiatry; 2021 Oct; 65(1):e18. PubMed ID: 34641986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of cariprazine in negative symptoms of schizophrenia: Post hoc analyses of PANSS individual items and PANSS-derived factors.
    Fleischhacker W; Galderisi S; Laszlovszky I; Szatmári B; Barabássy Á; Acsai K; Szalai E; Harsányi J; Earley W; Patel M; Németh G
    Eur Psychiatry; 2019 May; 58():1-9. PubMed ID: 30738380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of negative symptoms and depression in schizophrenia: revision of the SANS and how it relates to the PANSS and CDSS.
    Rabany L; Weiser M; Werbeloff N; Levkovitz Y
    Schizophr Res; 2011 Mar; 126(1-3):226-30. PubMed ID: 21115328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What are depressive symptoms in acutely ill patients with schizophrenia spectrum disorder?
    Schennach R; Riedel M; Obermeier M; Seemüller F; Jäger M; Schmauss M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Möller HJ
    Eur Psychiatry; 2015 Jan; 30(1):43-50. PubMed ID: 25541347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor analysis of symptom dimensions (psychotic, affective and obsessive compulsive symptoms) in schizophrenia.
    Grover S; Dua D; Chakrabarti S; Avasthi A
    Asian J Psychiatr; 2018 Dec; 38():72-77. PubMed ID: 29108803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity of the depressive dimension extracted from principal component analysis of the PANSS in drug-free patients with schizophrenia.
    El Yazaji M; Battas O; Agoub M; Moussaoui D; Gutknecht C; Dalery J; d'Amato T; Saoud M
    Schizophr Res; 2002 Jul; 56(1-2):121-7. PubMed ID: 12084426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of the concurrent validity of the Calgary Depression Scale for Schizophrenics (CDSS).
    Lançon C; Auquier P; Reine G; Bernard D; Toumi M
    J Affect Disord; 2000 May; 58(2):107-15. PubMed ID: 10781700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender Differences of Schizophrenia Patients With and Without Depressive Symptoms in Clinical Characteristics.
    Liu R; Fang X; Yu L; Wang D; Wu Z; Guo C; Teng X; Ren J; Zhang C
    Front Psychiatry; 2021; 12():792019. PubMed ID: 35095605
    [No Abstract]   [Full Text] [Related]  

  • 10. The Persian version of the Calgary Depression Scale for Schizophrenia (CDSS-P).
    Rostami R; Kazemi R; Khodaie-Ardakani MR; Sohrabi L; Ghiasi S; Sadat Kamali Z; Zaryabi A; Ghiasi Z; Nasiri Z; Rezaei M; Addington DE
    Asian J Psychiatr; 2019 Oct; 45():44-49. PubMed ID: 31493624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of depression with cognitive insight and socio-occupational outcome in patients with schizophrenia.
    Grover S; Sahoo S; Nehra R; Chakrabarti S; Avasthi A
    Int J Soc Psychiatry; 2017 May; 63(3):181-194. PubMed ID: 28162014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validity study of the Brazilian version of the Calgary Depression Scale for Schizophrenia.
    Bressan RA; Chaves AC; Shirakawa I; de Mari J
    Schizophr Res; 1998 Jun; 32(1):41-9. PubMed ID: 9690333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of depression and its relationship with other clinical characteristics in a sample of patients with stable schizophrenia.
    Majadas S; Olivares J; Galan J; Diez T
    Compr Psychiatry; 2012 Feb; 53(2):145-51. PubMed ID: 21621754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. European Validation of the Self-Evaluation of Negative Symptoms (SNS): A Large Multinational and Multicenter Study.
    Dollfus S; Mucci A; Giordano GM; Bitter I; Austin SF; Delouche C; Erfurth A; Fleischhacker WW; Movina L; Glenthøj B; Gütter K; Hofer A; Hubenak J; Kaiser S; Libiger J; Melle I; Nielsen MØ; Papsuev O; Rybakowski JK; Sachs G; Üçok A; Brando F; Wojciak P; Galderisi S
    Front Psychiatry; 2022; 13():826465. PubMed ID: 35173641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating depressive symptoms in schizophrenia: a psychometric comparison of the Calgary Depression Scale for Schizophrenia and the Hamilton Depression Rating Scale.
    Schennach R; Obermeier M; Seemüller F; Jäger M; Schmauss M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Riedel M; Möller HJ
    Psychopathology; 2012; 45(5):276-85. PubMed ID: 22796716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic validity of assessment scales for depression in patients with schizophrenia.
    Kim SW; Kim SJ; Yoon BH; Kim JM; Shin IS; Hwang MY; Yoon JS
    Psychiatry Res; 2006 Sep; 144(1):57-63. PubMed ID: 16904189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of cariprazine on negative symptoms in patients with acute schizophrenia: A post hoc analysis of pooled data.
    Earley W; Guo H; Daniel D; Nasrallah H; Durgam S; Zhong Y; Patel M; Barabássy Á; Szatmári B; Németh G
    Schizophr Res; 2019 Feb; 204():282-288. PubMed ID: 30172595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linking PANSS negative symptom scores with the Clinical Global Impressions Scale: understanding negative symptom scores in schizophrenia.
    Leucht S; Barabássy Á; Laszlovszky I; Szatmári B; Acsai K; Szalai E; Harsányi J; Earley W; Németh G
    Neuropsychopharmacology; 2019 Aug; 44(9):1589-1596. PubMed ID: 30836381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the Brief Negative Symptom Scale and its association with functioning.
    Ang MS; Rekhi G; Lee J
    Schizophr Res; 2019 Jun; 208():97-104. PubMed ID: 30987926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Clinical Effects of Novel Partial D3/D2 Agonist Cariprazine in Schizophrenia Patients With Predominantly Negative Symptoms (Open-Label, Non-controlled Study).
    Ivanov SV; Smulevich AB; Voronova EI; Yakhin KK; Beybalaeva TZ; Katok AA
    Front Psychiatry; 2021; 12():770592. PubMed ID: 35140638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.